A Randomized, Double-blinded, Placebocontrolled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study

Ju-Yup LEE; Nayoung KIM; Hyuk YOON; Cheol-Min SHIN; Young-Soo PARK; Dong-Ho LEE.
Journal of Neurogastroenterology and Motility ; : 265-275, 2022.
Artículo en Inglés | WPRIM | ID: wpr-926119

Documentos relacionados

  1. A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study.
  2. [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].
  3. Effects of open-label placebos in clinical trials: a systematic review and meta-analysis.